Defining the role of SINE retrotransposons and inflammasome activation in Alzheimer's disease
定义 SINE 逆转录转座子和炎症小体激活在阿尔茨海默病中的作用
基本信息
- 批准号:10696066
- 负责人:
- 金额:$ 62.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-15 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:Abeta clearanceAge related macular degenerationAgingAlu ElementsAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAmyloid beta-ProteinAnatomyAnimal Disease ModelsAnimal ModelBehavioralBrainCASP1 geneCellsCharacteristicsChronicCicatrixCognitiveComplexDNA Transposable ElementsDegenerative DisorderDepositionDevelopmentElementsEpidemiologyEyeFoundationsFutureGeneticGenetic TranscriptionGenomeHumanHuman CharacteristicsHuman GenomeIL18 geneImmuneImmune responseImmune signalingImmunologyImpairmentIndividualInflammasomeInflammationInflammatoryInterleukin-1 betaKnowledgeLicensingLinkMapsMediatingMicrogliaModelingMolecularMultiple SclerosisMusNerve DegenerationNeurofibrillary TanglesNuclearParkinson DiseasePathogenesisPathogenicityPathologicPathologyPathway interactionsPhagocytosisPhosphorylationProteinsRNARNA HelicaseRNA Polymerase IIIRetrotranspositionRetrotransposonRoleScienceSenile PlaquesShort Interspersed Nucleotide ElementsSignal PathwaySignal TransductionSourceStructure of retinal pigment epitheliumTechniquesTestingTherapeuticTherapeutic InterventionToxic effectTranscriptTranslational ResearchVisualizationabeta accumulationabeta depositionage related neurodegenerationbrain cellcell typecognitive functioncytokinecytotoxicityefficacy testingfunctional outcomesgenetic elementhyperphosphorylated tauimmune activationimprovedinhibitormouse genomemouse modelneuroinflammationnovelpharmacologicprogressive neurodegenerationprotein aggregationsensorsmall molecule inhibitorspatiotemporaltargeted treatmenttau Proteinstau aggregationtherapeutic evaluation
项目摘要
PROJECT SUMMARY
Pathological hallmarks of Alzheimer's disease (AD) include deposition of Amyloid-β (Aβ) plaques and
accumulation of hyperphosphorylated Tau aggregates in neurofibrillary tangles. These aggregates have been
demonstrated to activate inflammasome signaling. Inflammasomes are innate immune platforms implicated in
numerous chronic neurodegenerative and inflammatory conditions such as AD. Inflammasome inhibition is being
explored as a therapeutic strategy for AD and other complex neuroinflammatory/degenerative disorders including
Parkinson's disease, multiple sclerosis, and age-related macular degeneration (AMD). Recent studies have
identified links between dysregulation of transposable elements (TEs) and AD. We have established a critical
mechanistic role for activity of one class of TEs – short interspersed elements (SINEs) – in the pathogenesis of
AMD. We have demonstrated that SINE RNA accumulation induces cellular degeneration in AMD by dual
activation of the NLRP3 and NLRC4 inflammasomes. Furthermore, we have identified DDX17, an RNA helicase,
as the molecular sensor of SINE RNAs that licenses dual activation of the inflammasomes. Moreover, our
preliminary studies have identified dysregulation of SINE RNAs in spatial proximity to Aβ deposits in the 5xFAD
model of AD and that a novel small molecule inhibitor of NLRC4-NLRP3 signaling suppresses inflammasome
activation induced by Aβ aggregates.
Notwithstanding these findings, major gaps in knowledge about SINE RNAs and inflammasomes in AD persist,
e.g, the cellular sources of SINE RNAs in AD are undefined and whether SINE RNAs interact with and activate
inflammasome components in AD is unknown. This proposal will test the hypothesis that AD pathology is
exacerbated by NLRP3/NLRC4 activation induced by endogenous SINE RNA accumulation. We will test this
hypothesis via three specific aims: 1) We will quantitate SINE RNA expression and inflammasome activation and
map their cellular origins in the 5xFAD model of AD; 2) We will determine the cellular mechanisms of SINE RNA-
induced inflammasome activation in brain microglia, whether SINE RNA compromises Aβ phagocytosis by
microglia, and whether inflammasome inhibitors improve Aβ phagocytosis; and 3) We will test the effects of
individual and dual inflammasome inhibitors on Aβ clearance as well as cognitive and behavioral deficits in the
5xFAD model. Collectively, these thematically related but independent aims will shed light on the contribution of
SINE RNAs-induced inflammasome activation in AD. This project is responsive to RFA-AG-22-021 as it will (a)
define the functional roles and causal relationships between SINE RNAs and neuroinflammation; (b) define the
mechanisms underpinning innate and immune responses to SINE RNAs; and (c) test therapeutic interventions
interfering with SINE RNA-mediated molecular pathways. These studies will provide a deeper mechanistic
understanding of the role of TEs that can serve as a foundation for future translational research.
项目概要
阿尔茨海默病 (AD) 的病理标志包括淀粉样蛋白 -β (Aβ) 斑块的沉积和
神经原纤维缠结中过度磷酸化的 Tau 聚集体的积累。
被证明可以激活炎症小体信号传导。炎症小体是与炎症相关的先天免疫平台。
许多慢性神经退行性疾病和炎症性疾病,例如 AD,正在被抑制。
探索作为 AD 和其他复杂神经炎症/退行性疾病的治疗策略,包括
最近的研究表明,帕金森病、多发性硬化症和年龄相关性黄斑变性(AMD)。
确定了转座因子 (TE) 失调与 AD 之间的联系。
一类 TE 的活性(短散布元件 (SINE))在疾病发病机制中的机制作用
AMD 我们已经证明 SINE RNA 积累通过双重作用诱导 AMD 细胞变性。
NLRP3 和 NLRC4 炎性体的激活此外,我们还鉴定了 DDX17,一种 RNA 解旋酶,
作为 SINE RNA 的分子传感器,可实现炎症小体的双重激活。
初步研究已发现 5xFAD 中 Aβ 沉积物空间附近的 SINE RNA 失调
AD 模型以及 NLRC4-NLRP3 信号传导的新型小分子抑制剂可抑制炎症小体
Aβ 聚集体诱导的激活。
尽管有这些发现,关于 AD 中的 SINE RNA 和炎症小体的知识仍然存在重大差距,
例如,AD 中 SINE RNA 的细胞来源尚不清楚,SINE RNA 是否与 AD 相互作用并激活
AD 中的炎症小体成分尚不清楚,该提案将检验 AD 病理学的假设。
NLRP3/NLRC4 内源性 SINE RNA 积累诱导的激活会加剧这种情况,我们将对此进行测试。
通过三个具体目标提出假设:1)我们将定量 SINE RNA 表达和炎性体激活,
在 AD 的 5xFAD 模型中绘制它们的细胞起源;2) 我们将确定 SINE RNA-的细胞机制
诱导脑小胶质细胞炎症小体激活,SINE RNA 是否通过影响 Aβ 吞噬作用
小胶质细胞,以及炎性体抑制剂是否改善 Aβ 吞噬作用;以及 3)我们将测试其效果;
单独和双重炎性体抑制剂对 Aβ 清除以及认知和行为缺陷的影响
总的来说,这些主题相关但独立的目标将阐明 5xFAD 模型的贡献。
AD 中 SINE RNA 诱导的炎症小体激活 该项目对 RFA-AG-22-021 具有响应性,因为它会 (a)
(b) 定义 SINE RNA 与神经炎症之间的功能作用和因果关系;
SINE RNA 的先天反应和免疫反应的机制;以及 (c) 测试治疗干预措施;
这些研究将提供更深入的机制。
了解 TE 的作用,可以作为未来转化研究的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jayakrishna Ambati其他文献
Jayakrishna Ambati的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jayakrishna Ambati', 18)}}的其他基金
Cytosolic SINE retrotransposable element cDNA and mitochondrial DNA in aging retina
衰老视网膜中的胞质 SINE 逆转录转座元件 cDNA 和线粒体 DNA
- 批准号:
10722062 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
Defining the role of SINE retrotransposons and inflammasome activation in Alzheimer's disease
定义 SINE 逆转录转座子和炎症小体激活在阿尔茨海默病中的作用
- 批准号:
10517678 - 财政年份:2022
- 资助金额:
$ 62.08万 - 项目类别:
Visual system and cognitive biology in normal animals versus in an animal model of Alzheimer's disease with or without diabetes treated with solo or dual inflammasome inhibitors
正常动物的视觉系统和认知生物学与单独或双重炎性体抑制剂治疗的患有或不患有糖尿病的阿尔茨海默病动物模型的比较
- 批准号:
10712956 - 财政年份:2020
- 资助金额:
$ 62.08万 - 项目类别:
Nlrp3 inflammasome activation in early diabetic retinopathy - Administrative Supplement ERG Request
早期糖尿病视网膜病变中 Nlrp3 炎症小体激活 - 行政补充 ERG 请求
- 批准号:
10643583 - 财政年份:2020
- 资助金额:
$ 62.08万 - 项目类别:
Inflammasome-based Alzheimer's disease therapy in the context of diabetes
糖尿病背景下基于炎症小体的阿尔茨海默病治疗
- 批准号:
10287353 - 财政年份:2020
- 资助金额:
$ 62.08万 - 项目类别:
Nlrp3 inflammasome activation in early diabetic retinopathy
早期糖尿病视网膜病变中 Nlrp3 炎性体激活
- 批准号:
10414049 - 财政年份:2020
- 资助金额:
$ 62.08万 - 项目类别:
Nlrp3 inflammasome activation in early diabetic retinopathy
早期糖尿病视网膜病变中 Nlrp3 炎性体激活
- 批准号:
10626060 - 财政年份:2020
- 资助金额:
$ 62.08万 - 项目类别:
Non-canonical inflammasome in activation in RPE degeneration
RPE 变性中激活的非典型炎症小体
- 批准号:
10338080 - 财政年份:2019
- 资助金额:
$ 62.08万 - 项目类别:
Antigen-independent suppression of ocular angiogenesis via the Fc receptor
通过 Fc 受体对眼部血管生成进行抗原非依赖性抑制
- 批准号:
10192726 - 财政年份:2018
- 资助金额:
$ 62.08万 - 项目类别:
Antigen-independent suppression of ocular angiogenesis via the Fc receptor
通过 Fc 受体对眼部血管生成进行抗原非依赖性抑制
- 批准号:
10437790 - 财政年份:2018
- 资助金额:
$ 62.08万 - 项目类别:
相似国自然基金
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GNAS介导OPN4-PLCβ4-TRPC6/7通路调节自主感光视网膜神经节细胞在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301229
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
HTRA1介导CTRP5调控脂代谢通路在年龄相关性黄斑变性中的致病机制研究
- 批准号:82301231
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
视网膜色素上皮细胞中NAD+水解酶SARM1调控自噬溶酶体途径参与年龄相关性黄斑变性的机制研究
- 批准号:82301214
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向年龄相关性黄斑变性诊断的迁移学习算法研究
- 批准号:62371328
- 批准年份:2023
- 资助金额:53 万元
- 项目类别:面上项目
相似海外基金
Functional Ocular Chemoproteomics for Retinal Biology Insight and in vivo Enzyme Activity
用于视网膜生物学洞察和体内酶活性的功能性眼部化学蛋白质组学
- 批准号:
10667228 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
Identifying mechanistic pathways underlying RPE pathogenesis in models of pattern dystrophy
识别模式营养不良模型中 RPE 发病机制的机制途径
- 批准号:
10636678 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
Imaging spatial transcriptome at single cell resolution to study eye regeneration in old age
以单细胞分辨率对空间转录组进行成像以研究老年眼再生
- 批准号:
10785595 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
Partial epigenetic reprogramming of retinal pigment cells in age-related degeneration, dysfunction, and injury
视网膜色素细胞在年龄相关变性、功能障碍和损伤中的部分表观遗传重编程
- 批准号:
10644270 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别: